- Home
- CKX vs BOLT Comparison
CKX vs BOLT Comparison
Compare CKX & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CKX
- BOLT
- Stock Information
- Founded
- CKX 1930
- BOLT 2015
- Country
- CKX United States
- BOLT United States
- Employees
- CKX N/A
- BOLT N/A
- Industry
- CKX Oil & Gas Production
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- CKX Energy
- BOLT Health Care
- Exchange
- CKX Nasdaq
- BOLT Nasdaq
- Market Cap
- CKX 22.7M
- BOLT 22.6M
- IPO Year
- CKX 1998
- BOLT 2021
- Fundamental
- Price
- CKX $11.72
- BOLT $0.49
- Analyst Decision
- CKX
- BOLT Hold
- Analyst Count
- CKX 0
- BOLT 5
- Target Price
- CKX N/A
- BOLT $1.25
- AVG Volume (30 Days)
- CKX 8.6K
- BOLT 113.0K
- Earning Date
- CKX 01-01-0001
- BOLT 03-20-2025
- Dividend Yield
- CKX N/A
- BOLT N/A
- EPS Growth
- CKX N/A
- BOLT N/A
- EPS
- CKX 0.22
- BOLT N/A
- Revenue
- CKX $2,030,981.00
- BOLT $9,779,000.00
- Revenue This Year
- CKX N/A
- BOLT $9.87
- Revenue Next Year
- CKX N/A
- BOLT N/A
- P/E Ratio
- CKX $50.56
- BOLT N/A
- Revenue Growth
- CKX 88.35
- BOLT 35.86
- 52 Week Low
- CKX $10.60
- BOLT $0.46
- 52 Week High
- CKX $14.44
- BOLT $1.56
- Technical
- Relative Strength Index (RSI)
- CKX 53.65
- BOLT 45.52
- Support Level
- CKX $11.19
- BOLT $0.48
- Resistance Level
- CKX $11.60
- BOLT $0.52
- Average True Range (ATR)
- CKX 0.32
- BOLT 0.03
- MACD
- CKX 0.06
- BOLT 0.00
- Stochastic Oscillator
- CKX 90.51
- BOLT 40.32
About CKX CKX Lands Inc.
CKX Lands Inc is a Louisiana corporation organized to receive non-producing mineral royalties spun off by a southwest Louisiana bank. It operates in three segments: Oil and Gas, Surface, and Timber. The company owns land and mineral interests and collects income through its ownership in the form of oil and gas royalties, surface leases for farming, the right of way and other uses, and timber sales. The company's oil and gas royalties are paid by the operators who own the wells and timber income is paid by the highest bidder for the timber. CKX has small royalty interests in approximately 20 different producing oil and gas fields.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.